CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 36 enrolled
Drug / intervention
Niti-S SPAXUS Stentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02730663
NCT02730663N/ACompleted
CompareCT.gov

A Prospective, Multi-center, Single Arm, Non-inferiority, Open-label, Pivotal Study to Evaluate the Effectiveness and Safety of EUS -Guided Transluminal Drainage With 'Niti-S SPAXUS Stent' for the Treatment of Pancreatic Pseudocyst

Taewoong Medical Co., Ltd.·interventional·Posted Apr 6, 2016·Updated Sep 17, 2019

In Brief

A clinical study evaluating Niti-S SPAXUS Stent for Pancreatic Pseudocyst. Completed, enrolled 36 participants across 6 sites.

Detailed Summary

The purpose of this study is to evaluate the safety and effectiveness of endoscopic ultrasound (EUS)-guided transluminal drainage with 'Niti-S SPAXUS Stent' for the treatment of pancreatic pseudocyst.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPancreatic Pseudocyst
CountriesSouth Korea
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 6, 2016
Enrollment StartMar 21, 2016
Primary CompletionJun 14, 2017
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 10.2 years ago

Interventions

Niti-S SPAXUS Stentdevice

Endoscopic Ultrasound-Guided Transluminal drainage